Roux-en-Y (RNY) gastric bypass is a type of weight-loss surgery in which the stomach is divided into a small upper pouch and a larger lower "remnant" portion. The small intestine is rearranged to connect to both. This reduces the stomach's capacity and alters how the body absorbs calories and nutrients, making it one of the most effective bariatric surgeries for long-term weight loss. Patients can expect significant weight loss, but the procedure is more complex than other forms of bariatric surgery, requiring... +More

The cost of Roux-en-Y gastric bypass surgery varies based on location, healthcare provider, and whether the patient has insurance coverage. In the U.S., the cost ranges from $20,000 to $30,000, depending on the hospital and specific circumstances. In countries with public healthcare systems, such as the UK or Canada, the surgery may be covered, though waiting times could be long. Many insurance companies in the U.S. cover bariatric surgery if it’s deemed medically necessary, but patients must meet specific... +More

Weight-loss injections such as Saxenda or Wegovy can lead to side effects like nausea, vomiting, diarrhea, constipation, and abdominal pain. In rare cases, patients may experience gallbladder issues or pancreatitis. It’s important to monitor for side effects and adjust dosage as needed under medical supervision.

Gastric band tablets are not a recognized treatment, but the term might refer to weight-loss medications that mimic the effects of a gastric band by suppressing appetite or blocking fat absorption. Medications like Orlistat or appetite suppressants are sometimes used in combination with bariatric procedures.

This is another term for the Roux-en-Y gastric bypass surgery, where the stomach is divided into a small pouch and a large "remnant," with the small intestine rerouted to connect to both. It is a more complex surgery compared to other weight-loss procedures but has a high success rate in achieving long-term weight loss.

Before-and-after images of gastric sleeve patients highlight not only the weight loss but also the excess skin that may remain, especially in areas like the abdomen. Many patients opt for skin removal surgeries after achieving their weight-loss goals.

Feeling sick in your stomach can indicate nausea, indigestion, or an underlying condition such as gastritis, food intolerance, or stress. If persistent, it’s essential to consult a healthcare provider for proper diagnosis and treatment.

A non-surgical sleeve refers to procedures that mimic the effects of sleeve gastrectomy but without surgery. One such method is the Endoscopic Sleeve Gastroplasty (ESG), which reduces stomach size using sutures inserted through an endoscope. This approach is less invasive, has a faster recovery time, and is typically used for patients who do not qualify for surgical interventions.

Gastritis treatment focuses on reducing inflammation in the stomach lining. This may involve antacids, proton pump inhibitors, or antibiotics if caused by H. pylori infection. Lifestyle changes, such as avoiding spicy foods, alcohol, and NSAIDs, can also help manage symptoms.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

A mini gastric bypass is a simpler version of the traditional RNY gastric bypass. It involves creating a small stomach pouch and bypassing a section of the small intestine. This procedure is less invasive and typically quicker to perform, with fewer complications. It offers similar weight-loss results to the traditional bypass but may result in higher rates of bile reflux. It is becoming a popular choice for those looking for effective weight-loss surgery with a shorter recovery time.

The "fat jab," also known as Saxenda or liraglutide, is an injectable weight-loss drug that has been approved for use on the NHS in the UK for individuals struggling with obesity. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity. The medication helps control appetite, leading to weight loss. It is typically prescribed to those with a BMI over 30 or individuals with weight-related health problems.

The long-term effects of sleeve gastrectomy include sustained weight loss, improvement or resolution of obesity-related conditions such as type 2 diabetes, hypertension, and sleep apnea. However, patients may also experience long-term nutritional deficiencies, requiring them to take supplements like vitamin B12, calcium, and iron. Regular follow-up with healthcare providers is essential to monitor these effects.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

The Allurion Balloon is not yet widely available on the NHS, though some private clinics in the UK offer it. This non-invasive procedure is an attractive option for individuals seeking a temporary weight-loss solution without the risks associated with surgery.